All Articles

Tennessee Oncology's new Tullahoma center isn't just a building. It's a calculated move in the decentralization of advanced medicine, a model reshaping patient care and regional economies.

With the hire of practitioner-turned-executive Diana Dennett, CLEARSTEM isn't just scaling. It's betting its future on a new C-suite archetype.

The Oncology Institute's transformation into Starling Oncology signals a strategic pivot to solve the cancer cost crisis through a tech-enabled, coordinated model.

How a boutique airline used a historic baseball moment to cement its brand in L.A., celebrating Taiwanese pride and redefining corporate sponsorship.

SHEIN's new kids' collection with influencer Cheyenne Davis showcases a savvy marketing strategy, but can philanthropy and affordability outweigh fast fashion's ethical cost?

With the appointment of Ph.D. holder and patent inventor Bruce Christensen as CEO, FORTA signals a strategic shift towards accelerated, tech-driven growth.

Powerus just landed a major Air Force contract, but the real story is its pending merger with a golf course operator. We dissect the risks and rewards of this unorthodox deal.

As mainframes face a talent crisis, Izzi Software's Z/XDC debugger on VS Code aims to attract new developers. Is this the key to securing vital legacy systems?

With $100M in total funding, bioinformatics firm Inocras plans to challenge U.S. precision oncology leaders by leveraging its whole-genome sequencing success in Asia.

As AI agents proliferate, a new class of threats emerges. The Cloud Security Alliance, with Rubrik, is launching a new center to build enterprise resilience.

As legacy data protection fails in the AI era, ORION Security's rapid growth signals a market shift. Is their 'agentic' AI the answer to alert fatigue?

A pivotal CMS ruling grants Carlsmed's AI-driven spinal implants a dedicated payment code, unlocking market access and signaling a new era for med-tech.

The nationwide launch of Ritual's prenatal vitamin at Costco is more than a distribution win; it's a stress test for a new retail model based on clinical proof.

Cohen & Company's Q2 results showcase its mastery of the resurgent SPAC market. With revenue soaring to $69.5M and major deals inked, the boutique firm proves that specialized expertise can deliver outsized returns.

As Sonida Senior Living prepares its Q2 results, investors are watching closely. Can the operator prove its massive merger is paying off amidst industry-wide cost pressures?

McNally Capital's majority stake in TENICA signals a strategic shift, with private equity now a key player in funding America's next-gen cyber and space defense.

Amidst the fallout of its CEO's ouster, Anavex Life Sciences unveils a new board slate to fend off an activist investor's bid for total control.

As global baby gear giant Joie enters Canada, it's not just about strollers. It's a test of retail strategy, a challenge to safety standards, and a bold move in a multi-billion dollar market.

Guidewire's new Qusar release introduces an 'Agentic Framework,' moving AI from isolated experiments to the core of P&C operations. Is this the key to durable value?

Faced with impossible costs and AI anxiety, Gen Z and Millennials are delaying the American Dream. But they aren't giving up—they're rewriting the rules.